Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Bone Fracture Global Clinical Trials Review, H1, 2017
Publication Date May 2017
Product Type Report
Pages 282
Single User License help $ 2500.00
Site User License help $ 5000.00
Corporate User License help $ 7500.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

Bone Fracture Global Clinical Trials Review, H1, 2017

Summary

GlobalData's clinical trial report, “Bone Fracture Global Clinical Trials Review, H1, 2017" provides an overview of Bone Fracture clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Fracture. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Companies Mentioned

Novartis AG Pfizer Inc Eli Lilly and Company Takeda Pharmaceutical Company Ltd GlaxoSmithKline Plc OrgaNext Research BV Amgen Inc Intas Pharmaceuticals Ltd Merck & Co Inc Kuros Biosciences AG

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Bone Fracture to Musculoskeletal Disorders Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Bone Fracture to Musculoskeletal Disorders Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Bone Fracture Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profile Snapshots 31
Appendix 279
Abbreviations 279
Definitions 279
Research Methodology 280
Secondary Research 280
About GlobalData 281
Contact Us 281
Source 281

List of Tables
List of Tables
Bone Fracture Therapeutics, Global, Clinical Trials by Region, 2017* 7
Bone Fracture Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Bone Fracture Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Bone Fracture Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Bone Fracture Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Bone Fracture Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Bone Fracture Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 14
Bone Fracture Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 15
Proportion of Bone Fracture to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2017* 16
Bone Fracture Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Bone Fracture Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Bone Fracture to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2017* 19
Bone Fracture Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Bone Fracture Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Bone Fracture Therapeutics, Global, Clinical Trials by Phase, 2017* 22
Bone Fracture Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
Bone Fracture Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Bone Fracture Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Bone Fracture Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Bone Fracture Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
Bone Fracture Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Bone Fracture Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Bone Fracture Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List of Figures
List of Figures
Bone Fracture Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Bone Fracture Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Bone Fracture Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Bone Fracture Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Bone Fracture Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Bone Fracture Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Bone Fracture Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 14
Bone Fracture Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 15
Proportion of Bone Fracture to Musculoskeletal Disorders Clinical Trials, G7 Countries (%), 2017* 16
Bone Fracture Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Bone Fracture Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Bone Fracture to Musculoskeletal Disorders Clinical Trials, E7 Countries (%), 2017* 19
Bone Fracture Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Bone Fracture Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Bone Fracture Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
Bone Fracture Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
Bone Fracture Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Bone Fracture Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Bone Fracture Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Bone Fracture Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
Bone Fracture Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Bone Fracture Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Bone Fracture Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
GlobalData Methodology 280

Title Date Price
Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report
By QYResearch
The Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Digital Camera Head for Endoscopes industry. The re ...Read More
Apr 2016 $3600.00
China Pharmaceutical Guidebook Series (4) Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines
By Access China Management Consulting Ltd
The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of tradition ...Read More
May 2015 $750.00
Latest Guide to Chinese Pharmaceutical GMP Regulations
By Access China Management Consulting Ltd
China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2012, sales on the Chinese drug market have reached RMB 926.1billion (about US$147 billion) ...Read More
Jul 2015 $750.00
"Acne vulgaris "- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acne vulgaris  - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and ...Read More
Apr 2016 $4950.00
"Acute coronary syndrome(ACS)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute coronary syndrome (ACS) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of th ...Read More
Apr 2016 $4950.00
"Acute heart failure(AHF)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute heart failure (AHF) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the di ...Read More
Apr 2016 $4950.00
"Acute ischemic stroke (AIS)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute ischemic stroke (AIS) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the ...Read More
Apr 2016 $4950.00
"Acute lymphoblastic leukemia (ALL)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Acute lymphoblastic leukemia (ALL) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview ...Read More
Apr 2016 $4950.00
"Age-related macular degeneration (AMD)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Age-related macular degeneration (AMD) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overv ...Read More
Apr 2016 $4950.00
"Alzheimer’s disease (AD)"- Market Insights, Epidemiology and Market Forecast-2020
By Delveinsight
Note*: This report requires 5-10 business days to complete.DelveInsight’s Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the d ...Read More
Apr 2016 $4950.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

Published By :  GlobalData

For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z